High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study
Background. Contrast-induced nephropathy (CIN) is a significant complication of angiographic procedures resulting from injection of iodinated contrast media (CM). Patients with diabetes mellitus (DM) are at the highest risk of CIN. Statins have recently been proposed for protection against CIN due t...
Auteurs principaux: | Ahmed Abdel-Galeel, Salma Taha, Khaled M. Elmaghraby, Ramadan Ghaleb, Amr Hanafy, Fabrizio D’Ascenzo, M. Abdelfatah Elsharef, Lobna Abdel-Wahid, Ayman Ibrahim |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Hindawi-Wiley
2021-01-01
|
Collection: | Journal of Interventional Cardiology |
Accès en ligne: | http://dx.doi.org/10.1155/2021/8862316 |
Documents similaires
-
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
par: Ayman Ibrahim, et autres
Publié: (2020-12-01) -
Cardiac effects of direct anti-viral treatment in type II diabetic patients with hepatitis C infection
par: Khaled M. Elmaghraby, et autres
Publié: (2024-07-01) -
Atorvastatin and prevention of contrast induced nephropathy following coronary angiography
par: Peyman Bidram, et autres
Publié: (2015-01-01) -
Correlation between ankle–brachial index, wall motion score index, and SYNTAX score in acute coronary syndrome patients
par: Abdel-Galeel Ahmed, et autres
Publié: (2022-06-01) -
Effects of combined use of atorvastatin and losartan in treating patients with diabetic nephropathy
par: Chao Ding, et autres
Publié: (2018-10-01)